Catalyst Wire Dossier Catalyst Wire Dossier

Silver biomaterial nano-formulation (32 ppm)

silver biomaterial nano-formulation · University of Utah
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Silver biomaterial nano-formulation (32 ppm), covering 2015-10-26 to 2015-10-26. Get the full timeline:

Most recent: Clinical Trial Update: In-Vivo Assessment of Silver Biomaterial Nano-Toxicity 32 Ppm [Phase 1, Phase 2]

See pricing